Antigen Presentation Pathway
SITC 2019 Poster
Potent ERAP1 inhibitors modify the immunopeptidome and generate novel neoantigens.
Please leave this field empty.
* I consent to giving the above information to Grey Wolf Therapeutics. I am aware my details will be saved for contact and marketing purposes.
Find out more.